You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BACITRACIN ZINC-POLYMYXIN B SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Bacitracin Zinc-polymyxin B Sulfate, and what generic alternatives are available?

Bacitracin Zinc-polymyxin B Sulfate is a drug marketed by Naska and is included in one NDA.

The generic ingredient in BACITRACIN ZINC-POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bacitracin Zinc-polymyxin B Sulfate

A generic version of BACITRACIN ZINC-POLYMYXIN B SULFATE was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB on January 26th, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BACITRACIN ZINC-POLYMYXIN B SULFATE?
  • What are the global sales for BACITRACIN ZINC-POLYMYXIN B SULFATE?
  • What is Average Wholesale Price for BACITRACIN ZINC-POLYMYXIN B SULFATE?
Summary for BACITRACIN ZINC-POLYMYXIN B SULFATE
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
DailyMed Link:BACITRACIN ZINC-POLYMYXIN B SULFATE at DailyMed
Drug patent expirations by year for BACITRACIN ZINC-POLYMYXIN B SULFATE
Recent Clinical Trials for BACITRACIN ZINC-POLYMYXIN B SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)N/A
Glaxo WellcomeN/A

See all BACITRACIN ZINC-POLYMYXIN B SULFATE clinical trials

US Patents and Regulatory Information for BACITRACIN ZINC-POLYMYXIN B SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Naska BACITRACIN ZINC-POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;TOPICAL 062849-001 Nov 13, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.